Huiqin Chen

Incidence and Outcome of <i>BRCA</i> Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Ana M. González-Angulo, Kirsten M. Timms, Shuying Liu et al. · Clinical Cancer Research · 2011 · 604 citations · Full text

Medicine, Genetics, Oncology +17

Loss of <i>HER2</i> Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

Elizabeth A. Mittendorf, Yun Wu, Maurizio Scaltriti et al. · Clinical Cancer Research · 2009 · 334 citations · Full text

Medicine, Oncology, Surgery +17

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Yan Xing, Nancy U. Lin, Matthew Maurer et al. · Breast Cancer Research · 2019 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

Ana M. González-Angulo, Jaime Ferrer-Lozano, Katherine Stemke‐Hale et al. · Molecular Cancer Therapeutics · 2011 · 218 citations · Full text

Medicine, Cancer Biology, Oncology +13

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric‐Bernstam, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 208 citations · Full text

Medicine, Oncology, Pharmacology +16